InvestorsHub Logo
Followers 4
Posts 2989
Boards Moderated 0
Alias Born 02/17/2017

Re: colbeyt1 post# 64801

Tuesday, 08/18/2020 9:43:34 AM

Tuesday, August 18, 2020 9:43:34 AM

Post# of 113920
Noxopharm is an Australian publicly-listed (ASX: NOX) clinical stage drug development company.

The clinical stage drug candidate is Veyonda® (previously known as NOX-66). Veyonda® is a first-in-class, dual-acting cytotoxic and immuno-oncology drug candidate designed to enhance the effectiveness and safety of both chemotherapy and radiotherapy.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News